Northern Trust’s MediciNova MNOV Stock Holding History

Northern Trust’s Portfolio MNOV Stock Details MNOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$182K	Hold	133,163	–	–	﹤0.01%	3972
2025 Q4	$174K	Sell	133,163 -1,580	-1%	-$2.18K	﹤0.01%	4024
2025 Q3	$171K	Sell	134,743 -4,995	-4%	-$6.46K	﹤0.01%	4024
2025 Q2	$183K	Sell	139,738 -1,013	-0.7%	-$1.42K	﹤0.01%	3964
2025 Q1	$205K	Sell	140,751 -261	-0.2%	-$462	﹤0.01%	3935
2024 Q4	$296K	Hold	141,012	–	–	﹤0.01%	3851
2024 Q3	$296K	Sell	141,012 -4,883	-3%	-$7.22K	﹤0.01%	3745
2024 Q2	$210K	Sell	145,895 -7,579	-5%	-$10.6K	﹤0.01%	3852
2024 Q1	$223K	Sell	153,474 -82	-0.1%	-$116	﹤0.01%	3861
2023 Q4	$230K	Sell	153,556 -143	-0.1%	-$258	﹤0.01%	3847
2023 Q3	$321K	Sell	153,699 -488	-0.3%	-$1.14K	﹤0.01%	3641
2023 Q2	$355K	Sell	154,187 -1,555	-1%	-$3.43K	﹤0.01%	3628
2023 Q1	$336K	Sell	155,742 -6,485	-4%	-$14.9K	﹤0.01%	3612
2022 Q4	$333K	Sell	162,227 -596	-0.4%	-$1.32K	﹤0.01%	3639
2022 Q3	$353K	Buy	162,823 +3,276	+2%	+$7.58K	﹤0.01%	3623
2022 Q2	$403K	Sell	159,547 -1,428	-0.9%	-$3.73K	﹤0.01%	3620
2022 Q1	$430K	Sell	160,975 -1,823	-1%	-$4.47K	﹤0.01%	3792
2021 Q4	$437K	Buy	162,798 +11,602	+8%	+$38.8K	﹤0.01%	3860
2021 Q3	$573K	Buy	151,196 +499	+0.3%	+$1.9K	﹤0.01%	3720
2021 Q2	$641K	Sell	150,697 -366,572	-71%	-$1.58M	﹤0.01%	3634
2021 Q1	$2.61M	Sell	517,269 -80,901	-14%	-$471K	﹤0.01%	3109
2020 Q4	$3.15M	Sell	598,170 -27,170	-4%	-$156K	﹤0.01%	2946
2020 Q3	$3.28M	Sell	625,340 -20,330	-3%	-$117K	﹤0.01%	2785
2020 Q2	$3.5M	Buy	645,670 +81,893	+15%	+$434K	﹤0.01%	2740
2020 Q1	$2.1M	Buy	563,777 +23,432	+4%	+$122K	﹤0.01%	2830
2019 Q4	$3.64M	Sell	540,345 -15,439	-3%	-$116K	﹤0.01%	2779
2019 Q3	$4.42M	Buy	555,784 +29,886	+6%	+$266K	﹤0.01%	2623
2019 Q2	$5.07M	Buy	525,898 +19,750	+4%	+$208K	﹤0.01%	2556
2019 Q1	$4.19M	Buy	506,148 +8,074	+2%	+$70.4K	﹤0.01%	2654
2018 Q4	$4.07M	Sell	498,074 -629	-0.1%	-$6.28K	﹤0.01%	2631
2018 Q3	$6.23M	Buy	498,703 +43,573	+10%	+$438K	﹤0.01%	2563
2018 Q2	$3.62M	Buy	455,130 +38,551	+9%	+$399K	﹤0.01%	2863
2018 Q1	$4.26M	Buy	416,579 +45,255	+12%	+$451K	﹤0.01%	2689
2017 Q4	$2.4M	Buy	371,324 +1,103	+0.3%	+$7.32K	﹤0.01%	3037
2017 Q3	$2.36M	Buy	370,221 +1,622	+0.4%	+$8.63K	﹤0.01%	3073
2017 Q2	$1.94M	Buy	368,599 +35,331	+11%	+$198K	﹤0.01%	3184
2017 Q1	$2M	Sell	333,268 -2,984	-0.9%	-$18K	﹤0.01%	3083
2016 Q4	$2.03M	Buy	336,252 +16,797	+5%	+$118K	﹤0.01%	3082
2016 Q3	$2.39M	Buy	319,455 +1,887	+0.6%	+$12.7K	﹤0.01%	2984
2016 Q2	$2.4M	Buy	317,568 +276,676	+677%	+$2M	﹤0.01%	2927
2016 Q1	$300K	Buy	40,892 +5,422	+15%	+$26.9K	﹤0.01%	3602
2015 Q4	$126K	Hold	35,470	–	–	﹤0.01%	3882
2015 Q3	$100K	Buy	35,470 +15,735	+80%	+$53.7K	﹤0.01%	3936
2015 Q2	$78K	Buy	19,735 +1,079	+6%	+$4.26K	﹤0.01%	3989
2015 Q1	$65K	Hold	18,656	–	–	﹤0.01%	4116
2014 Q4	$57K	Hold	18,656	–	–	﹤0.01%	4076
2014 Q3	$56K	Sell	18,656 -43	-0.2%	-$98	﹤0.01%	4126
2014 Q2	$38K	Sell	18,699 -71	-0.4%	-$138	﹤0.01%	4137
2014 Q1	$38K	Buy	18,770 +5,057	+37%	+$11.3K	﹤0.01%	4078
2013 Q4	$29K	Hold	13,713	–	–	﹤0.01%	4013
2013 Q3	$35K	Hold	13,713	–	–	﹤0.01%	3964
2013 Q2	$36K	Buy	+13,713	New	+$40.4K	﹤0.01%	3964

Other funds holding MNOV

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Northern Trust's MNOV Position: Q1 2026 in Review

Northern Trust held its MediciNova (MNOV) position steady in Q1 2026 at 133,163 shares worth $182K. The position accounts for ﹤0.01% of the portfolio, ranked #3972.

Northern Trust first reported a position in MNOV in Q2 2013 and has held it in 52 quarters since. The position peaked at $6.23M in Q3 2018. 30 funds tracked by Wall St. Rank hold MNOV as of Q1 2026.

Northern Trust held 133,163 shares of MediciNova worth $182K as of Q1 2026.
Northern Trust left its MediciNova share count unchanged in Q1 2026.
MediciNova made up ﹤0.01% of Northern Trust's portfolio in Q1 2026, its #3972 holding.
Northern Trust first reported a position in MediciNova in Q2 2013 and has held it in 52 quarters since.
Northern Trust's MediciNova position peaked at $6.23M in Q3 2018.
30 funds tracked by Wall St. Rank held MediciNova as of Q1 2026.

Based on Northern Trust's 13F filing for Q1 2026, filed 14 May 2026.